Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Board Appointment

25 Nov 2014 07:00

RNS Number : 8702X
Byotrol PLC
25 November 2014
 



 

25 November 2014

 

Byotrol plc

BOARD APPOINTMENT

 

Byotrol plc ("Byotrol" or "the company", the leading AIM listed anti-microbial hygiene company, today announces the appointment of Dr Trevor Francis to its board as Chief Technology Officer with immediate effect.

 

Dr Francis has been working as a consultant to the Company in various positions over the last six years, particularly in consumer product development and commercialisation. Prior to joining Byotrol, Dr Francis spent 29 years at Unilever where he became Vice President of the Global R&D Homecare division and Head of the European Fabric Conditioners & Global Fragrance divisions.

 

Dr Francis is also a board trustee of the Liverpool School of Tropical Medicine where he serves on the Audit and Remuneration Committees.

 

Commenting on the appointment, Nicholas Martel, Chairman of Byotrol, said:

 

"We are delighted to welcome Trevor to the Board. His proven experience of delivering innovative products to market will be invaluable as we seek to consolidate on the recent improvements made within the Company."

 

The following information in relation to the appointment of Dr Francis is disclosed pursuant to Schedule 2(g) of the AIM Rules for Companies:

 

Full Name: Dr Thomas Trevor Francis

Age: 64

 

Current Directorships and Partnerships

Directorships and Partnerships held in the last five years

Tecnoform Associates Limited

None

Liverpool School of Tropical Medicine

 

Shareholding in Company

Options held over Company Shares

% Shareholding in Company post option exercise

Trevor Francis

739,846

2,250,000

1.33%

 

Dr Francis does not have a cash bonus scheme for the financial year ending 31 March 2015.

 

The options for Dr Francis have been granted in the Company's Enterprise Management Incentive Scheme.

 

There are no other matters which are required to be disclosed pursuant to Schedule 2(g) of the AIM Rules for Companies.

 

Enquiries:

 

Byotrol plc

01925 742 000

David Traynor - Chief Executive

Dawn Williams - Group Marketing Controller

 

 

finnCap Ltd

020 7220 0500

Geoff Nash

Christopher Raggett

 

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading anti-microbial technology company, operating globally in the Food, Industrial, Healthcare and Consumer sectors, providing low toxicity products with a broad-based and long-lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, mycobacteria and algae.

Powerful, long-lasting and gentle, Byotrol's products can be used stand alone or as an ingredient within existing products, where Byotrol can significantly improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives for everyone.

 

For more information, please go to www.byotrol.co.uk 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGGMCGUPCGRC
Date   Source Headline
20th Aug 20151:00 pmRNSPlacing and Subscription to raise £1.4 million
14th Aug 20157:00 amRNSPosting of Annual Report and Notice of AGM
4th Aug 20157:00 amRNSAgreement with Solvay
1st Jul 20158:25 amRNSHolding(s) in Company
15th Jun 20157:00 amRNSPreliminary Results
16th Apr 20157:00 amRNSTrading update
25th Nov 20147:01 amRNSInterim Results
25th Nov 20147:00 amRNSBoard Appointment
10th Nov 201410:58 amRNSNotice of Interim Results
17th Sep 20141:08 pmRNSHolding(s) in Company
29th Jul 20143:35 pmRNSResult of AGM and Completion of Placing
24th Jul 20147:00 amRNSGrant of Options
7th Jul 20147:00 amRNSANNUAL REPORT AND AGM NOTICE
25th Jun 20147:00 amRNSConditional Fundraising of £1.25m
25th Jun 20147:00 amRNSUnaudited Preliminary Results
18th Mar 20147:00 amRNSTrading Update and Directorate Changes
20th Dec 20137:00 amRNSFundraising
19th Nov 20137:00 amRNSInterim Results
31st Oct 20137:00 amRNSTotal Voting Rights
17th Oct 20133:04 pmRNSHolding(s) in Company
10th Oct 20133:11 pmRNSHolding(s) in Company
9th Oct 20137:00 amRNSDirectorate Change
3rd Oct 20137:00 amRNSAcquisition
15th Aug 20138:34 amRNSDirector/PDMR Shareholding
13th Aug 20133:12 pmRNSDirector/PDMR Shareholding
9th Aug 20132:47 pmRNSDirector/PDMR Shareholding
9th Aug 20138:20 amRNSHolding(s) in Company
25th Jul 20133:54 pmRNSResult of AGM
1st Jul 20139:28 amRNSDirector/PDMR Shareholding
25th Jun 20137:01 amRNSIssue of Equity
25th Jun 20137:00 amRNSFinal Results
19th Apr 20137:00 amRNSDirectorate Change
19th Mar 20137:00 amRNSJDA with Albaad Ltd for UK & Europe
8th Feb 20137:00 amRNSCommercial & Trading Update
20th Nov 20127:00 amRNSInterim Results
1st Oct 20129:44 amRNSDirector/PDMR Shareholding
16th Aug 201210:25 amRNSDirector/PDMR Shareholding
14th Aug 20126:08 pmRNSHolding(s) in Company
13th Aug 20127:00 amRNSLicensing Agreement with Kimberly-Clark
25th Jul 20127:00 amRNSHolding(s) in Company
23rd Jul 20128:03 amRNSHolding(s) in Company
19th Jul 20123:33 pmRNSResult of AGM
19th Jul 20127:00 amRNSAGM Statement
17th Jul 201211:10 amRNSDirector/PDMR Shareholding
6th Jul 20127:00 amRNSGrant of Options
27th Jun 20127:00 amRNSDirectorate Change + Annual Report + AGM notice
19th Jun 20127:00 amRNSPreliminary Results
12th Apr 20127:00 amRNSTrading Update
10th Feb 201210:54 amRNSHolding(s) in Company
31st Jan 20122:00 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.